435 related articles for article (PubMed ID: 22153664)
1. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
3. Immune Complexes in Juvenile Idiopathic Arthritis.
Moore TL
Front Immunol; 2016; 7():177. PubMed ID: 27242784
[TBL] [Abstract][Full Text] [Related]
4. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
5. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
Biró E; Nieuwland R; Tak PP; Pronk LM; Schaap MC; Sturk A; Hack CE
Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
[TBL] [Abstract][Full Text] [Related]
6. Role of IgM & IgA rheumatoid factors in complement activation in patients with juvenile rheumatoid arthritis.
Bhardwaj A; Aggarwal A; Agarwal V; Misra R
Indian J Med Res; 2000 Mar; 111():103-9. PubMed ID: 10937386
[TBL] [Abstract][Full Text] [Related]
7. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
8. Evidence for activation of the alternate complement pathway in patients with juvenile rheumatoid arthritis.
Aggarwal A; Bhardwaj A; Alam S; Misra R
Rheumatology (Oxford); 2000 Feb; 39(2):189-92. PubMed ID: 10725071
[TBL] [Abstract][Full Text] [Related]
9. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK
Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682
[TBL] [Abstract][Full Text] [Related]
10. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
11. Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study.
Gilliam BE; Chauhan AK; Low JM; Moore TL
Clin Exp Rheumatol; 2008; 26(3):492-7. PubMed ID: 18578976
[TBL] [Abstract][Full Text] [Related]
12. Localization of circulating immune complexes from patients with rheumatoid arthritis in murine spleen germinal centres.
Mageed RA; Kirwan JR; Holborow EJ
Scand J Immunol; 1991 Sep; 34(3):323-31. PubMed ID: 1882188
[TBL] [Abstract][Full Text] [Related]
13. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
14. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
[TBL] [Abstract][Full Text] [Related]
15. Binding of complement component C1q to anti-beta2 glycoprotein I antibodies from patients with antiphospholipid syndrome.
Odorczuk M; Keil LB; DeBari VA
Inflamm Res; 1999 Oct; 48(10):524-6. PubMed ID: 10563468
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
Duvall MR; Hwang HY; Boackle RJ
Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
[TBL] [Abstract][Full Text] [Related]
17. Anti-citrullinated peptide antibodies in Sudanese patients with Leishmania donovani infection exhibit reactivity not dependent on citrullination.
Åhlin E; Elshafie AI; Nur MA; Rönnelid J
Scand J Immunol; 2015 Mar; 81(3):201-8. PubMed ID: 25565324
[TBL] [Abstract][Full Text] [Related]
18. Increased amounts of C4-containing immune complexes and inefficient activation of C3 and the terminal complement pathway in a patient with homozygous C2 deficiency and systemic lupus erythematosus.
Garred P; Mollnes TE; Thorsteinsson L; Erlendsson K; Steinsson K
Scand J Immunol; 1990 Jan; 31(1):59-64. PubMed ID: 2300790
[TBL] [Abstract][Full Text] [Related]
19. Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis.
Low JM; Chauhan AK; Moore TL
Scand J Immunol; 2007 Jan; 65(1):76-83. PubMed ID: 17212770
[TBL] [Abstract][Full Text] [Related]
20. Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies.
Banda NK; Wood AK; Takahashi K; Levitt B; Rudd PM; Royle L; Abrahams JL; Stahl GL; Holers VM; Arend WP
Arthritis Rheum; 2008 Oct; 58(10):3081-9. PubMed ID: 18821684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
